跳至主要内容
临床试验/IRCT20100123003140N22
IRCT20100123003140N22招募中3 期

Effect of menaquinone (MK-7) supplementation on metabolic, nutritional, inflammatory status and matrix ?- carboxyglutamate protein in DMII

Tabriz University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 55 years(—)
性别
All

入选标准

  • Men and non-postmenopausal women,
  • With type 2 diabetes (at least from 6 months prior to the study),
  • With desire to participate in the study,
  • Age of 20-55 years,
  • BMI 27-35 kg/m2,
  • Who use anti diabetic drugs.

排除标准

  • Pregnancy, lactation, menopause, hormone therapy, use of vitamin K containing contraceptives, polycystic ovary syndrome;
  • Presence of diseases affecting vascular calcification or cardiac dysfunction;
  • History of bone, rheumatoid arthritis, thyroid, parathyroid, liver, kidney, intestine disease or malignancies;
  • Presence of infectious or inflammatory disease symptoms or recent surgery;
  • Use of insulin, corticosteroids and anticoagulant drugs such as warfarin and coumarin;
  • Adherence to a specific diet and consumption of any dietary supplements or weight reducing drugs for 3 month prior to the study;

研究者

相似试验

已完成
不适用
effect of Menaquinone(MK-7) supplementation on deppression status in patients with polycystic ovary syndrome
IRCT20170916036204N5Shiraz University of Medical Sciences84
进行中(未招募)
不适用
The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone HealthCoronary Artery CalcificationArterial Stiffness
NCT05259046Bispebjerg Hospital450
已完成
3 期
Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis patients: A Multicenter Randomized Controlled TrialChange of cfPWV and progression of arterial stiffness after 12 and 24 weeks of oral MK-7 supplementation, Change of biochemistry parameters, vascular and bone turnover markers in blood after 12 and 24 weeks of oral MK-7 treatment, Incidence of side effects, thrombotic events and death from MK-7 supplementMenaquinone-7, Arterial stiffness, Carotid-femoral pulse wave velocity, Chronic hemodialysis
TCTR20230217001Chulalongkorn University86
已完成
2 期
Effect of Menaquinone supplementation on insulin resistance, lipid profile, anthropometric measurments, endocrine markers and oxidative stress in patients with polycystic ovary syndrome who will be referred to health centers of Shiraz University of Medical Sciences, 1396.polycystic ovary syndrome.polycystic ovarian syndrome
IRCT2017092836204N2Vice chancellor for research, Shiraz University of Medical Sciences84
已完成
不适用
Beneficial Effects of Long Term Menaquinone-7Bone LossArteriosclerosis
NCT00642551Maastricht University Medical Center240
Effect of menaquinone supplementation in DMII | 临床试验